COVID-19 Comprehensive Resource Center

In this presentation, Dr. Sharon Lewin reviews recent data on investigational therapies for COVID-19, including TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: March 18, 2021

In this presentation, Vikram Mukherjee, MD, reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19.

Vikramjit Mukherjee, MD Released: February 19, 2021

In this presentation, Dr. Jens Lundgren reviews tests for SARS-CoV-2 infection, with emphasis on assays that detect viral antigens.

Jens D. Lundgren, MD, DMSc Released: January 29, 2021

In this presentation, Arthur Kim, MD, reviews recent EUAs for baricitinib, bamlanivimab, and casirivimab/imdevimab, as well as NIH guideline recommendations for ivermectin.

Arthur Kim, MD Released: January 25, 2021

In this presentation, Dr. Roger Paredes reviews safety and efficacy data on COVID-19 vaccines, as well as considerations for vaccine rollout.

Roger Paredes, MD, PhD Released: January 7, 2021

In this concise presentation, Professor Yee-Sin Leo reviews vaccine hesitancy data, and the factors that impact vaccine hesitancy.

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: December 24, 2020

In this presentation, Dr. Paul Sax reviews data on the relationship between HIV infection and COVID-19 outcomes.

Paul E. Sax, MD Released: December 10, 2020

In this presentation, Dr. Roger Paredes reviews the implications and prevalence of mutations in SARS-CoV-2.

Roger Paredes, MD, PhD Released: December 4, 2020

In this presentation, Dr. Vikram Mukherjee reviews recent studies on the epidemiology of COVID-19 in healthcare workers.

Vikramjit Mukherjee, MD Released: November 13, 2020

In this presentation, Professor Jens D. Lundgren reviews the currently available case report literature on reinfection with SARS-CoV-2.

Jens D. Lundgren, MD, DMSc Released: November 6, 2020

In this presentation, Professor Sharon Lewin discusses the FDA approval of remdesivir and the data from the ACTT-1 and WHO SOLIDARITY trials.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: October 30, 2020

In this presentation, Professor Leo Yee-Sin discusses the incidence of coinfections and superinfections in patients with COVID-19.

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: October 22, 2020

In this presentation, Jens D. Lundgren, MD, DMSc, discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19.

Jens D. Lundgren, MD, DMSc Released: October 16, 2020

In this presentation, Dr. Vikram Mukherjee discusses key recommendations for the management of common comorbidities in the context of COVID-19.

Vikramjit Mukherjee, MD Released: October 9, 2020

In this presentation, Dr. Adaora Adimora discusses recently published clinical trial and meta-analysis data on the use of corticosteroids to treat COVID-19.

Ada Adimora, MD, MPH Released: October 2, 2020

In this presentation, Dr. Wong Chen Seong discusses what is known about COVID-19 symptom persistence and the long-term pulmonary, cardiovascular, and neurologic sequelae in recovered patients

Dr Wong Chen Seong Released: September 25, 2020

In this presentation, Professor David Heymann provides an overview of the concept of herd immunity and considerations for estimating the herd immunity threshold for SARS-CoV-2.

David Heymann, BA, MD, DTM&H Released: September 18, 2020

In this presentation, Professor Jens D. Lundgren discusses the theory behind using convalescent plasma to treat infectious disease and the current evidence and recommendations regarding its use to treat patients with COVID-19.

Jens D. Lundgren, MD, DMSc Released: September 11, 2020

In this presentation, Professor Sharon Lewin discusses the recent data on the durability of antibody and T cell responses to SARS-CoV-2 and the implications for reinfection.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: September 4, 2020

In this concise presentation, Dr. Vikramjit Mukherjee discusses the presentation and burden of coagulopathy in COVID-19 and the data and recommendations on preventative therapy.

Vikramjit Mukherjee, MD Released: August 28, 2020

In this presentation, Professor David Heymann provides an update on the development and utility of current diagnostic tests for SARS-CoV-2, with special consideration to how various methods can be used in an epidemiological approach to limit community transmission.

David Heymann, BA, MD, DTM&H Released: August 21, 2020

In this presentation, Dr. Sigal Yawetz discusses the current data on COVID-19 risk and disease severity in pregnant women and newborns, treatment options during pregnancy, and best practices for postpartum management of mothers infected with COVID-19.

Sigal Yawetz, MD Released: August 14, 2020

In this presentation, Professor David Heymann discusses the current data on SARS-CoV-2 transmission, including mechanisms, timing, and protective strategies.

David Heymann, BA, MD, DTM&H Released: August 7, 2020

In this presentation, Professor Sharon Lewin discusses the rapid development of SARS-CoV-2 vaccines and the emerging safety and immunogenicity data from clinical trials investigating several vaccine candidates.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: July 31, 2020

In this concise presentation, Dr. Vikramjit Mukherjee discusses presentation and disease severity of COVID-19 in children and the diagnosis, incidence, and management of multisystem inflammatory syndrome in children.

Vikramjit Mukherjee, MD Released: July 24, 2020

In this presentation, Professor Jens D. Lundgren discusses the immune response to SARS-CoV-2 in relation to disease presentation and severity in immunocompromised patients, including solid organ transplant patients, patients on immunomodulatory therapies, and patients with HIV.

Jens D. Lundgren, MD, DMSc Released: July 17, 2020

In this concise presentation, Professor Jens D. Lundgren discusses the RECOVERY trial data and the updated guidance on administering dexamethasone to treat COVID-19.

Jens D. Lundgren, MD, DMSc Released: July 9, 2020

In this presentation, Dr. Vikramjit Mukherjee discusses medical management for severe to critical COVID-19, including the latest guidance and information on evolving treatment options.

Vikramjit Mukherjee, MD Released: July 2, 2020

In this presentation, Dr. Adaora Adimora discusses the disproportionate number of COVID-19 cases and deaths among Black and Latinx populations and factors that influence these disparities.

Ada Adimora, MD, MPH Released: June 25, 2020

In this presentation, Dr. Adaora Adimora discusses medical management for mild to moderate COVID-19, including current treatment recommendations and data on investigational therapies.

Ada Adimora, MD, MPH Released: June 18, 2020

In this presentation, Professor Leo Yee-Sin discusses COVID-19 clinical manifestation, including the current data on common symptoms, risk factors for severe disease, and disease course.

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: June 11, 2020

In this presentation, Professor Jens D. Lundgren discusses COVID-19 diagnosis, including clinical suspicion of infection and temporal considerations for detecting SARS-CoV-2 using current methods.

Jens D. Lundgren, MD, DMSc Released: June 4, 2020

In this presentation, Professor Sharon Lewin discusses the kinetics of the antibody response following SARS-CoV-2 infection, current tests for antibody detection, and the use of serology assays in COVID-19 diagnosis and epidemiological studies

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: May 28, 2020

In this concise presentation, Dr. Vikramjit Mukherjee discusses the indications, dosing guidelines, and special considerations outlined in the FDA emergency use authorization of remdesivir for treatment of COVID-19.

Vikramjit Mukherjee, MD Released: May 22, 2020